Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5‐HT3 receptor‐mediated responses in Xenopus oocytes

Synapse - Tập 46 Số 3 - Trang 150-156 - 2002
Murat Öz1, Li Zhang2, Marisela Morales3
1National Institute on Drug Abuse, Cellular Neurobiology Section, Baltimore, Maryland
2National Institute on Alcohol Abuse & Alcoholism, Laboratory of Molecular & Cellular Neurobiology, Bethesda, Maryland, 20892‐8205
3Cellular Neurophysiology Section, Baltimore, Maryland, 21224

Tóm tắt

Abstract

The cloned 5‐HT3 receptor from NCB‐20 neuroblastoma cells was expressed in Xenopus oocytes and the effect of the endogenous cannabinoid ligand, anandamide, was investigated on the function of this receptor. The oocytes expressing the cloned 5‐HT3 receptors were voltage‐clamped at −70 mV. Anandamide, at the concentration range of 0.1–100 μM, reversibly inhibited 1 μM 5‐HT induced currents. The inhibition of 5‐HT induced currents by anandamide was concentration‐dependent with an EC50 of 3.7 μM and slope value of 0.94. This inhibitory effect was not dependent on the membrane potential and anandamide did not have an effect on the reversal potential of 5‐HT‐induced currents. In the presence of 10 μM anandamide, the maximum 5‐HT‐induced response was also inhibited and the respective EC50 values were 3.4 μM and 3.1 μM in the absence and presence of anandamide, indicating that anandamide acts as a noncompetitive antagonist on 5‐HT3 receptors. CB1 receptor antagonist SR‐141716A (1 μM) and pertussis toxin (5 μg/ml) did not cause a significant change on the inhibition of 5‐HT responses by anandamide. The effect of anandamide was not changed by preincubating the oocytes with 0.2 mM 8‐Br‐cAMP, a membrane‐permeable analog of cAMP, or Sp‐cAMPS (0.1 mM), a membrane‐permeable protein kinase A activator. These results suggest that the effect of anandamide is independent of the activation of cAMP pathway and not mediated by the activation of PTX sensitive G‐proteins. In conclusion, we demonstrated that the endogenous cannabinioid anandamide inhibits the function of 5‐HT3 receptors expressed in Xenopus oocytes in a cannabinoid‐receptor independent and noncompetitive manner. Synapse 46:150–156, 2002. Published 2002 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1023/A:1020968922151

10.1007/s002109900078

10.1093/emboj/20.24.7033

10.3109/10409238709086960

10.1038/16941

10.1038/339706a0

10.1073/pnas.91.14.6698

10.1126/science.1470919

10.1016/0952-3278(95)90077-2

Di Marzo V, 1994, Formation and inactivation of endogenous cannabinoid anadamide in central neurones, Nature, 372, 686, 10.1038/372686a0

10.1074/jbc.274.43.30799

10.1152/jn.1995.73.2.907

10.1016/0376-8716(95)01120-N

10.1016/0165-6147(93)90128-7

10.1016/0304-3940(95)11289-9

Hille B, 2001, Ion channels of excitable membranes

10.1016/S0197-0186(99)00054-6

10.1093/emboj/20.1.47

10.1016/S1054-3589(08)60437-8

10.1002/hipo.10025

10.1002/(SICI)1096-9861(19981221)402:3<385::AID-CNE7>3.0.CO;2-Q

10.1002/cne.1307

Oz M, 1995, Inhibition by the endogenous cannabinoid anandamide, of 5‐HT3 receptor‐mediated ion current in Xenopus oocytes, Proc Eur Symp Drug Addict AIDS, 3, 64

Oz M, 1998, Functional coupling of human L‐type Ca2+ channel and angiotensin AT1A receptor coexpressed in Xenopus oocytes, Mol Pharmacol, 54, 1106, 10.1124/mol.54.6.1106

10.1016/S0014-2999(00)00396-4

10.1016/0028-3908(96)00130-X

Sadler SE, 1983, Inhibition of Xenopus oocyte adenylate cyclase by progesterone and 2′,5′‐dideoxyadenosine is associated with slowing of guanine nucleotide exchange, J Biol Chem, 258, 7935, 10.1016/S0021-9258(20)82008-0

10.1210/endo-111-4-1385

Smith PB, 1994, The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice, J Pharmacol Exp Ther, 270, 219

10.1016/0896-6273(92)90121-S

10.1038/sj.bjp.0703521

10.1038/376590a0

White MM, 1981, Expression of functional pituitary somatostatin receptors in Xenopus oocytes, Proc Natl Acad Sci USA, 83, 133

10.1016/0896-6273(88)90111-0

10.1113/jphysiol.1991.sp018551

Wang SD, 2001, Differential expression of the 5‐HT3 receptor subunits A and B in CNS and PNS, Soc Neurosci, 27, 600.6